Search results
Covid Vaccine Side Effects: 4 Takeaways From Our Investigation
New York Times· 3 days agoThousands of Americans believe they experienced rare but serious side effects. Apoorva Mandavilli...
BioNTech Revenue Falls Sharply on Reduced Covid Vaccine Sales
Barrons.com· 2 hours agoFEATURE U.S.-listed shares of BioNTech were falling Monday after the German company that partnered...
UPDATE 1-BioNTech says 90% of 2024 revenues will accrue at end of year
Reuters via Yahoo Finance· 2 hours agoGermany's BioNTech , whose COVID-19 vaccine in partnership with Pfizer was widely used during the pandemic, said on Monday that almost ...
Thousands Believe Covid Vaccines Harmed Them. Is Anyone Listening?
New York Times· 3 days agoZimmerman, who believes her injury is due to a contaminated vaccine batch. The Covid vaccines, a...
Pfizer Inc (PFE) Q1 2024 Earnings: Adjusted EPS Surpasses Expectations Amidst Revenue Decline
GuruFocus.com via Yahoo Finance· 5 days agoStrategic and Operational Highlights Despite the challenges posed by declining COVID-19 product...
US opens COVID vaccine to little kids, shots begin next week
AOL· 7 days agoThe U.S. on Saturday opened COVID-19 vaccines to infants, toddlers and preschoolers. The shots will...
The true tragedy of the Covid-19 vaccines
The Telegraph via Yahoo News· 5 days agoVaccination is one of mankind’s most miraculous innovations. The eradication of smallpox, and the retreat of measles and other cruel afflictions, mean...
Pfizer lifts 2024 profit view on cost cuts, higher COVID vaccine demand
WHTC 1450 Holland· 5 days ago(Reuters) -Pfizer lifted its annual profit forecast on Wednesday, banking on cost cuts and...
Pfizer Stock Gets Boost From Better-Than-Expected Earnings
Investopedia· 5 days agoThe company posted adjusted net income, which doesn't account for items such as impact of...
Pfizer beats revenue estimates, raises profit outlook on cost cuts and strong non-Covid sales
CNBC· 5 days agoPfizer on Wednesday reported first-quarter revenue that beat expectations and hiked its full-year...